K123554 is an FDA 510(k) clearance for the SHUNTCHECK. Classified as Shunt, Central Nervous System And Components (product code JXG), Class II - Special Controls.
Submitted by Neurodx Development, LLC (Bensalem, US). The FDA issued a Cleared decision on March 7, 2013 after a review of 108 days - within the typical 510(k) review window.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5550 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.
NCT00583336
Unknown
Interventional
Industry-sponsored
Physician Preference Study of ShuntCheck - Madsen
Physician Preference Study of the Utility of ShuntCheck to Detect Cerebrospinal Fluid (CSF) in Patients With Ventriculo-Peritoneal CSF Shunts
| Condition studied |
CSF Flow Through the Shunt of a Hydrocephalus Patient |
| Study design |
Single group |
| Eligibility |
All sexes
|
| Principal investigator |
Joseph R Madsen, MD |
| Sponsor |
NeuroDx Development
(industry)
|
Started 2007-09-01
→
Primary completion 2015-07-01
→
Completed 2015-09-01
Primary outcome
ShuntCheck result of "Flow Confirmed" for asymptomatic shunted patients tested
Secondary outcome
ShuntCheck result of "Flow Not Confirmed" for symptomatic shunted patients with shunt obstruction
View full study on ClinicalTrials.gov